bf/NASDAQ:INZY_icon.jpeg

COM:INOZYME

Inozyme

  • Stock

1.21

+5.22%

−2.79

USD last updated 28/07 01:48:46

Last Close

4.00

30/06 22:06

Market Cap

285.77M

Beta: -

Volume Today

462.93K

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of c...Show More